Prevention of arterial thromboembolism in nonvalvular atrial fibrillation: validating molecular markers of risk stratification.
Gabig
T G
TG
D000367:Age Factors; D000941:Antigens / Q000097:blood; D001157:Arterial Occlusive Diseases / Q000150:complications* / Q000401:mortality / Q000517:prevention & control*; D001281:Atrial Fibrillation / Q000150:complications* / Q000378:metabolism / Q000401:mortality; D015415:Biomarkers / Q000097:blood; D005169:Factor VIII / Q000378:metabolism; D006801:Humans; D015995:Prevalence; D015203:Reproducibility of Results; D012307:Risk Factors; D012737:Sex Factors; D013923:Thromboembolism / Q000150:complications* / Q000401:mortality / Q000517:prevention & control*; D010959:Tissue Plasminogen Activator / Q000378:metabolism
D000941:Antigens; D015415:Biomarkers; D005169:Factor VIII; D010959:Tissue Plasminogen Activator